United Imaging
Chinese medical-technology company developing medical imaging and radiotherapy systems for hospitals and research institutions.
Last updated October 12, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
United Imaging, also known as United Imaging Healthcare or UIH, is a Chinese medical-technology company headquartered in Shanghai. It develops and manufactures high-end diagnostic imaging, molecular imaging, and radiotherapy equipment for hospitals, imaging centers, research organizations, and other healthcare providers. Its portfolio includes computed tomography systems, magnetic resonance imaging systems, positron-emission tomography and computed tomography systems, digital radiography equipment, and radiation-therapy products. The company presents itself as an integrated medical-equipment manufacturer rather than a single-modality specialist, combining hardware, clinical software, service, and research collaborations. The business was founded in 2011 by Xue Min and Zhang Qiang, both identified in reference material as former Siemens employees. Its creation reflected the development of a Chinese supplier intended to compete in technically demanding segments traditionally dominated by multinational companies such as Siemens Healthineers, GE HealthCare, and Philips Healthcare. United Imaging invested in research and development and expanded its product range across multiple imaging modalities, while building a commercial and service organization in China and abroad. International expansion became a major stage in the company’s development. United Imaging established an American research and development center in Houston in 2013. In 2018, it entered the North American market through participation in the annual meeting of the Radiological Society of North America, and Houston subsequently became its regional headquarters. The company’s North American headquarters officially opened in 2020. It later expanded its presence across more than 30 U.S. states, launched products in several imaging categories, and established or announced operations in markets including Europe, Asia-Pacific, and Canada. A Seattle research and development office was announced in 2024, while the company also reported receiving its first Health Canada approvals that year. The company’s growth was supported by demand for hospital equipment in China and by the wider importance of imaging infrastructure during the COVID-19 pandemic. Chinese health authorities identified scanners and X-ray systems as basic equipment requirements for hospitals during the pandemic period. United Imaging reported becoming profitable in 2020. The company also reported cumulative global system milestones, announcing installation of its 20,000th system in New York in 2022 and shipment of its 30,000th system from its Houston manufacturing facility for installation in the United States in 2024. These milestones describe equipment deployments rather than a separate consumer product brand. United Imaging completed an initial public offering on the Shanghai Stock Exchange’s STAR Market in August 2022 under ticker 688271.SH. The offering was reported as one of China’s largest IPOs of that year. Its shares rose sharply on the first trading day, although the company’s longer-term valuation and stock performance are separate from the operating identity of the United Imaging brand. The company continues to derive most of its revenue from China while maintaining overseas operations in more than 75 countries according to the cited reference material. The brand’s positioning is centered on high-end, innovation-led medical equipment with an emphasis on domestic Chinese engineering capability and international competitiveness. Its research network includes collaborations with Washington University School of Medicine and other academic institutions. United Imaging’s principal customers are institutional and professional rather than consumers, and its business depends on regulatory clearances, capital-equipment procurement, installation, clinical workflow integration, maintenance, and long-term service. The company remains active and competes in global medical imaging and radiotherapy markets.
History
United Imaging was founded in 2011 by Xue Min and Zhang Qiang, who reference material identifies as former Siemens employees. The company was established with private funding and was designed to develop high-end medical imaging and radiotherapy equipment in China. Its scope expanded beyond a single equipment category to include CT, MRI, PET-CT, digital radiography, molecular imaging, and radiotherapy systems. The company began building an international technical footprint in 2013 by establishing an American research and development center in Houston. A 2014 visit by Xi Jinping during a Shanghai trip brought additional public attention to the business. United Imaging’s international commercial expansion became more visible in 2018, when it attended the annual meeting of the Radiological Society of North America and entered the North American market. Houston became the company’s regional headquarters, and its North American headquarters officially opened in 2020. The COVID-19 period increased attention to hospital imaging capacity in China. Chinese health authorities listed scanners and X-ray systems among basic equipment requirements for hospitals during the pandemic. United Imaging became profitable in 2020, according to the cited company history. It continued to expand overseas, establishing a presence in countries across Europe, Asia-Pacific, and North America. The company has stated or reported operations in more than 75 countries, although most revenue continues to come from China. In August 2022, United Imaging completed an initial public offering on the Shanghai Stock Exchange STAR Market under ticker 688271.SH. The offering was reported as raising approximately US$1.6 billion and as one of China’s largest IPOs of that year. The shares reportedly rose 75% on their trading debut. The listing gave the company access to public capital while placing greater emphasis on disclosure, regulatory compliance, and investor reporting. United Imaging has used global system-installation milestones to describe its expansion. It announced installation of its 20,000th system in New York in 2022 and shipment of its 30,000th system from its Houston manufacturing facility for installation in the United States in 2024. In the same year, it announced a Seattle research and development office and reported its first Health Canada approvals. The company also maintains research relationships with Washington University School of Medicine and other academic institutions. Its principal global competitors include Siemens Healthineers, GE HealthCare, and Philips Healthcare. United Imaging remains an active medical-technology company focused on institutional healthcare equipment, clinical imaging, research collaboration, regulatory approvals, and international market development.
- 2024
30,000th system shipment announced
[1]The company announced shipment of its 30,000th global system from Houston for installation in the United States.
- 2024
Seattle R&D office and Health Canada approvals
[1]United Imaging announced a Seattle research and development office and its first Health Canada approvals.
- 2022
20,000th global system installed
[1]United Imaging announced installation of its 20,000th global system in New York.
- 2022
STAR Market listing
[1]United Imaging completed its initial public offering on the Shanghai Stock Exchange STAR Market.
- 2020
North American headquarters opens
[1]The company officially opened its North American headquarters in Houston and was reported to have become profitable.
- 2018
North American market entry
[1]United Imaging attended the Radiological Society of North America annual meeting and entered the North American market.
- 2013
American research center established
[1]The company established an American research and development center in Houston.
- 2011
Company founded
[1]United Imaging was founded by Xue Min and Zhang Qiang with private funding.
Products and positioning
High-end medical imaging and radiotherapy equipment supplier emphasizing research and development, integrated clinical solutions, and international competition.
Computed tomography
uCT 960+
The uCT 960+ is identified in the existing dossier as a flagship United Imaging CT offering. It belongs to the company’s high-end computed-tomography portfolio, which is intended for hospital diagnostic imaging and advanced clinical workflows. Specific technical specifications and launch details are not established by the supplied reference material.
Magnetic resonance imaging
uMR 890
The uMR 890 is identified as a flagship magnetic-resonance offering. It represents United Imaging’s participation in high-end MRI, an equipment category used for detailed soft-tissue and functional imaging. The supplied sources do not provide a verified launch year or complete technical specification set.
Molecular imaging and PET-CT
uMI 550
The uMI 550 is listed as a flagship United Imaging offering in the molecular-imaging portfolio. United Imaging develops PET-CT and related molecular-imaging systems for clinical diagnosis and research. Product-level launch information and specifications are not stated in the supplied reference material.
Computed tomography
United Imaging CT portfolio
United Imaging’s CT portfolio covers hospital and diagnostic-imaging applications and is one of the company’s core business areas. The range is positioned as high-end medical equipment and forms part of the company’s strategy to offer multiple imaging modalities under one brand.
Magnetic resonance imaging
United Imaging MRI portfolio
The MRI portfolio provides magnetic-resonance systems for clinical imaging and research environments. It includes the uMR line and supports United Imaging’s broader positioning as a multi-modality medical-imaging manufacturer.
Radiotherapy
United Imaging radiotherapy portfolio
United Imaging manufactures radiotherapy equipment in addition to diagnostic imaging systems. These products extend the company’s healthcare-equipment scope into radiation treatment, although the supplied sources do not identify individual radiotherapy product names or launch dates.
Controversies
Marketing campaigns
- 2018Radiological Society of North America market introduction
United States · North America
United Imaging used participation in the annual Radiological Society of North America meeting to support its entry into the North American market and present its imaging portfolio to professional healthcare audiences.
Outcome. Supported the establishment of a North American commercial presence.
Brand decisions
2024
Expand North American research and regulatory capabilitiesStrategyBackground
United Imaging was deepening its presence in North America through local research, manufacturing, commercialization, and regulatory activity.
Action taken
The company announced a Seattle research and development office and reported its first Health Canada approvals.
Aftermath
The announcements broadened the company’s North American technical footprint and supported access to the Canadian market.
2022
Complete initial public offeringM&ABackground
The company sought public-market financing to support its development and expansion as a medical-technology manufacturer.
Action taken
United Imaging listed on the Shanghai Stock Exchange STAR Market under ticker 688271.SH.
Aftermath
The offering became one of China’s larger IPOs of 2022 according to the cited reference, and the shares rose sharply on debut.
Reported IPO proceeds. Approximately US$1.6 billion raised (August 2022 IPO)
2018
Enter the North American marketStrategyBackground
United Imaging was expanding beyond China and seeking recognition among professional radiology and medical-imaging customers.
Action taken
The company attended the Radiological Society of North America annual meeting and began its North American market entry.
Aftermath
The company developed a broader U.S. presence, including operations in more than 30 states according to the cited reference material.
2013
Establish a U.S. research and development centerStrategyBackground
The company sought to develop international technical capabilities and prepare for overseas market expansion.
Action taken
United Imaging established an American research and development center in Houston.
Aftermath
Houston later became the company’s North American regional headquarters and manufacturing base.
Recent events
- 2024
United Imaging announces shipment of its 30,000th global system[1]
Other
The company announced shipment of its 30,000th system globally from its Houston manufacturing facility for installation in the United States.
- 2024
United Imaging expands North American research and regulatory activity[1]
Regulation
United Imaging announced a Seattle research and development office and reported receiving its first Health Canada approvals.
- 2022
United Imaging announces its 20,000th global system installation[1]
Other
The company announced installation of its 20,000th global system in New York.
- 2022
United Imaging completes Shanghai STAR Market IPO[1]
M&A
United Imaging became publicly listed on the Shanghai Stock Exchange STAR Market in August 2022. The offering was reported to have raised approximately US$1.6 billion, subject to the cited source’s reporting and time context.
- 2022
United Imaging shares rise on trading debut[1]
Other
The company’s shares were reported to have risen 75% on their first trading day after the IPO.
- 2020
United Imaging reports profitability[1]
Other
The company became profitable in 2020, according to the cited company history.
- 2020
United Imaging opens its North American headquarters[1]
Other
The company officially opened its North American headquarters in Houston, strengthening its regional commercial and operational presence.
- 2018
United Imaging enters the North American market[1]
Other
United Imaging participated in the Radiological Society of North America’s annual meeting and began a more formal commercial push into North America.
- 2014
Xi Jinping visits United Imaging during Shanghai trip[1]
Other
China’s General Secretary Xi Jinping visited the company during a trip to Shanghai, an event reflecting the company’s visibility in China’s medical-equipment sector.
- 2013
United Imaging establishes a Houston research and development center[1]
Other
The company established an American research and development center in Houston as part of its international technical and commercial expansion.
Sources9 sources
- 1United Imaging - Wikipediaen.wikipedia.org
- 2United Imaging official websiteunited-imaging.com
- 3United-Imaging: United Medical Imaging Healthcare Innovatorusa.united-imaging.com
- 4Company - United Imagingusa.united-imaging.com
- 5IPO披露员工行贿、职务侵占刑事案件mrcj.net.cn
- 6IPO披露员工行贿、职务侵占刑事案件manloong.com
- 7联影、天津大学联合发布全球首个磁共振脑机接口全栈式解决方案uMR神观163.com
- 8Resoundant Announces Partnership with United Imagingitnonline.com
- 9SyntheticMR AB partners with United Imagingprnewswire.com
Cite this profile: Cite the canonical profile. /brand-wiki/united-imaging · Editorial policy · How profiles are compiled